[Lani]

since writing that article Dr. Nicholson has written 24 more. If there are any die-hards who really want to know all the latest before making up their minds (and these are only his articles and there are scores writing on it, but he and Dr. Dowsett seem to be the most interested in this, I supply the following list of references--due to technical problems (my computer ignorance). I will list about 4 and then about another 20 in a second post):
21: Vicent MJ, Greco F, Nicholson RI, Paul A, Griffiths PC, Duncan R. Related Articles, Links
Polymer therapeutics designed for a combination therapy of hormone-dependent cancer.
Angew Chem Int Ed Engl. 2005 Jun 27;44(26):4061-6. No abstract available.
PMID: 15912547 [PubMed - in process]
22: Nicholson RI, Hutcheson IR, Britton D, Knowlden JM, Jones HE, Harper ME, Hiscox SE, Barrow D, Gee JM. Related Articles, Links
Growth factor signalling networks in breast cancer and resistance to endocrine agents: new therapeutic strategies.
J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):257-62. Epub 2005 Feb 8. Review.
PMID: 15860268 [PubMed - indexed for MEDLINE]
23: Taylor KM, Morgan HE, Johnson A, Nicholson RI. Related Articles, Links
Structure-function analysis of a novel member of the LIV-1 subfamily of zinc transporters, ZIP14.
FEBS Lett. 2005 Jan 17;579(2):427-32.
PMID: 15642354 [PubMed - indexed for MEDLINE]
24: Jones HE, Goddard L, Gee JM, Hiscox S, Rubini M, Barrow D, Knowlden JM, Williams S, Wakeling AE, Nicholson RI. Related Articles, Links
Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells.
Endocr Relat Cancer. 2004 Dec;11(4):793-814.
PMID: 15613453 [PubMed - indexed for MEDLINE]